Elevated serum levels of CXCL10 were consistently reported in patients with COVID-19, being positively correlated (together with CCL2) with increased disease severity and, more importantly with an increased risk of mortality (11, 65, 66). This evidence concerns the gene CCL2 and COVID-19.